Nuclear and mitochondrial signalling Akts in cardiomyocytes

Cardiovascular Research

Volumn 82, Issue 2, 2009, Pages 272-285

  Miyamoto, Shigeki ^a   Rubio, Marta ^b   Sussman, Mark A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Akt; Cardiomyocyte; Heart; Kinase; Mitochondria; Nucleus; Pim 1; PKB

Indexed keywords

CALCIUM; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE; PHOSPHATIDYLINOSITIDE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE;

CELL COMPARTMENTALIZATION; CELL MEMBRANE; CYTOLOGY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; HUMANS; MICE; MITOCHONDRIA, HEART; MODELS, ANIMAL; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOLS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-PIM-1; RATS; SIGNAL TRANSDUCTION;

EID: 67449156064     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp087     Document Type: Review

References (236)

1. Franke TF. Intracellular signaling by Akt: bound to be specific. Sci Signal 2008;1:pe29.
2. Gao X, Zhang J. Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains. Mol Biol Cell 2008;19:4366-4373.
3. Sasaki K, Sato M, Umezawa Y. Fluorescent indicators for Akt/protein kinase B and dynamics of Akt activity visualized in living cells. J Biol Chem 2003;278:30945-30951.
4. Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 2003;87: 1427-1435.
5. Rosner M, Hanneder M, Freilinger A, Hengstschlager M. Nuclear/cytoplasmic localization of Akt activity in the cell cycle. Amino Acids 2007;32:341-345.
6. Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008;27: 6473 6488.
7. Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell 2007;12:487-502.
8. Huang J, Manning BD. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 2009; 37:217 222.
9. Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 2008;415:333-344.
10. Foukas LC, Okkenhaug K. Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases. Arch Biochem Biophys 2003;414:13-18.
11. Calleja V, Alcor D, Laguerre M, Park J, Vojnovic B, Hemmings BA et al. Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol 2007;5:e95.
12. DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 2006;281:32841-32851.
13. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M et al. Akt1 is required for physiological cardiac growth. Circulation 2006; 113: 2097-2104.
14. Muslin AJ, DeBosch B. Role of Akt in cardiac growth and metabolism. Novartls Found Symp 2006;274:118-126. discussion 126-131, 152-115, 272-116.
15. Cameron AJ, De Rycker M, Calleja V, Alcor D, Kjaer S, Kostelecky B et al. Protein kinases, from B to C. Biochem Soc Trans 2007;35:1013-1017.
16. Milburn CC, Deak M, Kelly SM, Price NC, Alessi DR, Van Aalten DM. Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem J 2003;375:531-538.
17. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC[alpha], but Not S6K1. Dev Cell 2006;11:859-871.
18. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307: 1098-1101.
19. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004; 380:297 309.
20. Oudit GY, Penninger JM. Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 2009;82:250-260.
21. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000;101:660-667.
22. Miao W, Luo Z, Kitsis RN, Walsh K. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J MoI Cell Cardiol 2000;32: 2397-2402.
23. Tsujita Y, Muraski J, Shiraishi I, Kato T, Kajstura J, Anversa P et al. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natí Acad Sd USA 2006; 103:11946 11951.
24. Matsui T, Li L, del Monte F, Fukui Y, Franke TF, Hajjar RJ et al. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999; 100: 2373 2379.
25. Ricci C, Jong CJ, Schaffer SW. Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. Can J Physiol Pharmacol 2008; 86:166-172.
26. Negoro S, Oh H, Tone E1 Kunisada K, Fujio Y, Walsh K et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/ caspase-3 interaction. Circulation 2001;103:555-561.
27. Shiraishi I, Melendez J, Ahn Y, Skavdahl M, Murphy E, Welch S et al. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 2004;94:884-891.
28. Gude N, Muraski J, Rubio M, Kajstura J, Schaefer E, Anversa P et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 2006;99:381-388.
29. Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 2002;22:2799-809.
30. Matsui T, Li L, WU JC Cook SA, Nagoshi T, Picard MH et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 2002;277:22896-22901.
31. Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 1999;96:7421-7426.
32. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999;398:630-634.
33. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. JBiol Chem 1998;273:32377-32379.
34. Rota M, Boni A, Urbanek K, Padin-lruegas ME, Kajstura TJ, Fiore G et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res 2005;97:1332-1341.
35. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-460.
36. Lai HC, Liu TJ, Ting CT, Sharma PM, Wang PH. Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of Pl 3 kinase/Akt pathway. MoI Cell Endocrinol 2003;205:99-106.
37. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem 2004;279:4782-4793.
38. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17beta-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 2001 ;104:1419-1423.
39. Patten RD, Karas RH. Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med 2006; 16:69-75.
40. Wu CH, Liu JY, Wu JP, Hsieh YH, Liu CJ, Hwang JM et al. 17beta-estradiol reduces cardiac hypertrophy mediated through the up-regulation of PI3K/Akt and the suppression of calcineurin/NF-AT3 signaling pathways in rats. Life Sd 2005;78:347-356.
41. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, laccarino G et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 2002;99:12333- 12338.
42. Taniyama Y, lto M, Sato K, Kuester C, Veit K, Tremp G et al. Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J MoI Cell Cardiol 2005;38:375-385.
43. Schiekofer S, Shiojima I, Sato K, Galasso G, Oshima Y, Walsh K. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics 2006;27:156-170.
44. Samarel AM. IGF-1 overexpression rescues the failing heart. Circ Res 2002;90:631-633.
45. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 2001;88:1020 1027.
46. Sugden PH, Clerk A. Akt like a woman: gender differences in susceptibility to cardiovascular disease. Circ Res 2001 ;88:975 977.
47. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, Glembotski CC et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 2005;115:2716 2730.
48. Catalucci D, Condorelli G. Effects of Akt on cardiac myocytes: location counts. Circ Res 2006;99:339-341.
49. Sussman M. 'Akt'ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. Trends Cardiovasc Med 2007:17:235 240.
50. Muraski JA, Rota M, Misao Y, Fransioli J, Cottage C, Gude N et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 2007; 13: 1467-1475.
51. Wang R, Brattain MG. Akt can be activated in the nucleus. Cell Signal 2006;18:1722-1731.
52. Saji M, Vasko V, Kada F, Allbritton EH, Burman KD, Ringel MD. Akt1 contains a functional leucine-rich nuclear export sequence. Biochem Biophys Res Commun 2005:332:167 173.
53. Pekařsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sd USA 2000:97:3028 3033.
54. Koh H, Jee K, Lee B, Kim J, Kim D, Yun YH et al. Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); a novel nuclear target of Akt. Oncogene 1999;18:5115-5119.
55. Takaishi H, Konishi H, Matsuzaki H, Ono Y, Shirai Y, Saito N et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 1999;96:11836-11841.
56. del Peso L, Gonzalez VM, Hernandez R, Barr FG, Nunez G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 1999; 18: 7328-7333.
57. Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. MoI Cell Biol 2001;21:3534-3546.
58. Altiok S, Batt D, Altiok N, Papautsky A, Downward J, Roberts TM et al. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/Akt in breast cancer cells. J Biol Chem 1999;274: 32274-32278.
59. Hinton CV, Fitzgerald LD, Thompson ME. Phosphatidylinositol 3-kinase/ Akt signaling enhances nuclear localization and transcriptional activity of BRCA1. Exp Cell Res 2007;313:1735-1744.
60. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/ neu-overexpressing cells. Nat Cell Biol 2001;3:245-252.
61. Rossig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S. Aktdependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. MoI Cell Biol 2001;21:5644- 5657.
62. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1 ) at threonine 157 and modulation of its cellular localization. Nat Med 2002;8: 1145-1152.
63. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002;8:1153-1160.
64. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002;8:1136-1144.
65. Shin I, Rotty J, Wu FY, Arteaga CL. Phosphorylation of p27Kip1 atThr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. J Biol Chem 2005;280:6055-6063.
66. Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S et al. Cytoplasmic sequestration of p27 via Akt phosphorylation in renal cell carcinoma. Clin Cancer Res 2009; 15:81 -90.
67. Mayo LD, Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sd USA 2001;98:11598-11603.
68. Ashcroft M, Ludwig RL, Woods DB, Copeland TD, Weber HO, MacRae EJ et al. Phosphorylation of HDM2 by Akt. Oncogene 2002;21:1955- 1962.
69. Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. MoI Cell 2003;11:11 23.
70. Baldin V, Theis-Febvre N, Benne C, Froment C, Cazales M, Burlet-Schiltz O et al. PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation. Biol Cell 2003;95:547 554.
71. Katayama K, Fujita N, Tsuruo T. Akt/protein kinase B-dependent phosphorylation and inactivation of WEEIHu promote cell cycle progression at G2/M transition. MoI Cell Biol 2005;25:5725-5737.
72. Gervais M, Dugourd C, Muller L, Ardidie C, Canton B, Loviconi L et al. Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15. MoI Biol Cell 2006; 17:3940 3951.
73. Rosner M, Freilinger A, Hengstschlager M. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene 2007;26:521 531.
74. York B, Lou D, Noonan DJ. Tuberin nuclear localization can be regulated by phosphorylation of its carboxyl terminus. MoI Cancer Res 2006;4: 885 897.
75. Rosner M, Hengstschlager M. Cytoplasmic/nuclear localization of tuberin in different cell lines. Amino Acids 2007;33:575 579.
76. Rosner M, Freilinger A, Hanneder M, Fujita N, Lubec G, Tsuruo Tet al. p27Kip1 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 2007; 16:1541 -1556.
77. Ferrigno P, Silver PA. Regulated nuclear localization of stress-responsive factors: how the nuclear trafficking of protein kinases and transcription factors contributes to cell survival. Oncogene 1999;18:6129 6134.
78. Zhou BP, Hung MC. Novel targets of Akt, p21(Cipl/WAF1), and MDM2. Semin Oncol 2002;29:62-70.
79. Muraski JA, Fischer KM, Wu W, Cottage CT, Quijada P, Mason M et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc Natl Acad Sd USA 2008;105:13889-13894.
80. Matsuda T, Zhai P, Maejima Y, Hong C, Gao S, Tian B et al. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc Natl Acad Sd USA 2008; 105:20900 20905.
81. Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2002;99:907-912.
82. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000; 151:117-130.
83. Basso AD, Solit DB, Chiosis G, Giri B, Tsichlis P, Rosen N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem 2002; 277:39858-39866.
84. Solit DB, Basso AD, Olshen AB, Scher Hl, Rosen N. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res 2003;63:2139-2144.
85. Wu R, Kausar H, Johnson P, Montoya-Durango DE, Merchant M, Rane MJ. Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J Biol Chem 2007;282: 21598-21608.
86. Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P et al. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicintriggered oxidative stress and cardiotoxicity. Circ Res 2008; 103: 1270-1279.
87. Nakamura T, lnoue K, Ogawa S, Umehara H, Ogonuki N, Miki H et al. Effects of Akt signaling on nuclear reprogramming. Genes Cell 2008; 13:1269-1277.
88. Reed JC. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 2006;13:1378-1386.
89. Ye K, Ahn JY. Nuclear phosphoinositide signaling. Front Biosci 2008; 13: 540-548.
90. Kim SJ. Insulin rapidly induces nuclear translocation of PI3-kinase in HepG2 cells. Biochem MoI Biol lnt 1998;46:187-196.
91. Lu PJ, Hsu AL, Wang DS, Yan HY, Yin HL, Chen CS. Phosphoinositide 3-kinase in rat liver nuclei. Biochemistry 1998;37:5738-5745.
92. Martelli AM, Borgatti P, Bortul R, Manfredini M, Massari L, Capitani S et al. Phosphatidylinositol 3-kinase translocates to the nucleus of osteoblast-like MC3T3-E1 cells in response to insulin-like growth factor I and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor alpha. J Bone Miner Res 2000; 15:1716-1730.
93. Metjian A, Roll RL, Ma AD, Abrams CS. Agonists cause nuclear translocation of phosphatidylinositol 3-kinase gamma. A Gbetagamma-dependent pathway that requires the pHOgamma amino terminus. J Biol Chem 1999;274:27943-27947.
94. Ye K. PIKE GTPase-mediated nuclear signalings promote cell survival. Biochim Biophys Acta 2006;1761:570-576.
95. Ye K, Hurt KJ, Wu FY, Fang M, Luo HR, Hong JJ et al. Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell 2000;103:919-930.
96. Ye K, Snyder SH. PIKE GTPase: a novel mediator of phosphoinositide signaling. J Cell Sd 2004; 117:155 -161.
97. Deleris P, Bacqueville D, Gayral S, Carrez L, Salles JP, Perret B et al. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem 2003;278:38884-38891.
98. Lindsay Y, McCoull D, Davidson L, Leslie NR, Fairservice A, Gray A et al. Localization of agonist-sensitive Ptdlns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J Cell Sci 2006;119:5160- 5168.
99. Tanaka K, Horiguchi K, Yoshida T, Takeda M, Fujisawa H, Takeuchi K et al. Evidence that a phosphatidylinositol 3,4,5-trisphosphate-binding protein can function in nucleus. J Biol Chem 1999;274:3919 3922.
100. Ahn JY, Liu X, Cheng D, Peng J, Chan PK, Wade PA et al. Nucleophosmin/ B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol Cell 2005;18:435-445.
101. Lee SB, Xuan Nguyen TL, Choi JW, Lee KH, Cho SW, Liu Z et al. Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival. Proc Natl Acad Sd USA 2008; 105:16584 16589.
102. Gillooly DJ, Morrow IC, Lindsay M, Gould R, Bryant NJ, Gaullier JM et al. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J 2000;19:4577-4588.
103. Irvine RF. Nuclear lipid signalling. NatRevMol Cell Biol 2003;4:349-360.
104. Martelli AM, Tabellini G, Borgatti P, Bortul R, Capitani S, Neri LM. Nuclear lipids: new functions for old molecules? J Cell Biochem 2003; 88:455-461.
105. Neri LM, Milani D, Bertolaso L, Stroscio M, Bertagnolo V, Capitani S. Nuclear translocation of phosphatidylinositol 3-kinase in rat pheochromocytoma PC 12 cells after treatment with nerve growth factor. Cell MoI Biol (Noisy-le-grand) 1994;40:619 626.
106. Lim MA, Kikani CK, Wick MJ, Dong LQ. Nuclear translocation of 3'-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function. Proc Natl Acad Sci USA 2003;100: 14006-14011.
107. Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Freeh M et al. Role of translocation in the activation and function of protein kinase B. JSIoI Chem 1997;272:31515-31524.
108. Zini N, Ognibene A, Bavelloni A, Santi S, Sabatelli P, Baldini N et al. Cytoplasmic and nuclear localization sites of phosphatidylinositol 3-kinase in human osteosarcoma sensitive and multidrug-resistant Saos-2 cells. Histochem Cell Biol 1996;106:457-464.
109. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 1999;59:1820-1824.
110. Scheid MP, Parsons M, Woodgett JR. Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation. Mol Cell Biol 2005;25:2347-2363.
111. Adini I, Rabinovitz I, Sun JF, Prendergast GC, Benjamin LE. RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev 2003;17:2721-2732.
112. Zhu L, Hu C, Li J, Xue P, He X, Ge C et al. Real-time imaging nuclear translocation of Akt1 in HCC cells. Biochem Biophys Res Commun 2007;356:1038-1043.
113. Webster KA. Aktion in the nucleus. Circ Res 2004;94:856- 859.
114. Rubio MAD, Fischer K, Emmanuel GE, Gude N, Miyamoto S, Mishra S et al. Cardioprotective stimuli mediate phosphoinosotide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes. J MoI Cell Cardiol 2009; in press.
115. Walsh K. Akt signaling and growth of the heart. Circulation 2006; 113: 2032-2034.
116. BullockAN, Debreczeni J, Amos AL, Knapp S, Turk BE. Structure and substrate specificity of the Pim-1 kinase. J Biol Chem 2005;280: 41675-41682.
117. Hoover D, Friedmann M, Reeves R, Magnuson NS. Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J Biol Chem 1991;266:14018-14023.
118. Bachmann M, Hennemann H, Xing PX, Hoffmann I, Moray T. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem 2004;279:48319-48328.
119. Roh M, Gary B, Song C, Said-Al-Naief N, Tousson A, Kraft A et al. Overexpression of the oncogenic kinase Pim-1 leads to genomic instability. Cancer Res 2003;63:8079-8084.
120. Kim KT, Baird K, Ahn JY, Meltzer P, Lilly M, Levis M et al. Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. Blood 2005;105:1759-1767.
121. Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999;18:4022-4031.
122. Aho TL, Lund RJ, Ylikoski EK, Matikainen S, Lahesmaa R, Koskinen PJ. Expression of human pirn family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation. Immunology 2005; 116:82 88.
123. Wang Z, Bhattacharya N, Meyer MK, Seimiya H, Tsuruo T, Tonani JA et al. Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells. Arch Biochem Biophys 2001;390:9 18.
124. Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S. Identification of FIk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 2004;103:4536-4544.
125. Bhattacharya N, Wang Z, Davitt C, McKenzie IF, Xing PX, Magnuson NS. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 2002; 111:80 95.
126. Katakami N, Kaneto H, Hao H, Umayahara Y, Fujitani Y, Sakamoto K et al. Role of pim-1 in smooth muscle cell proliferation. J Biol Chem 2004;279:54742-54749.
127. Chen XP, Losman JA, Cowan S, Donahue E, Fay S, Vuong BQ et al. Pirn serine/threonine kinases regulate the stability of Socs-1 protein. Proc Natl Acad Sd USA 2002;99:2175-2180.
128. White E. The pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev 2003;17:1813-1816.
129. Krishnan N, Pan H, Buckley DJ, Buckley A. Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling. Endocrine 2003;20:123-130.
130. Jacobs MD, Black J, Futer O, Swenson L, Hare B, Fleming M et al. Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002. J Biol Chem 2005;280:13728-13734.
131. Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 2005;105:4477-4483.
132. Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA, Thompson CB. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev 2003;17:1841-1854.
133. Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, Jonkers J et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 2004; 24: 6104-6115.
134. Matsui T, Nagoshi T, Hong EG, Luptak I, Hartil K, Li L et al. Effects of chronic Akt activation on glucose uptake in the heart. Am J Physiol Endocrinol Metab 2006; 290: E789-E797.
135. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 2005;115:2128-2138.
136. Shiojima I, Sato K, Izumiya Y, SchiekoferS, ItoM, LiaoR et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-2118.
137. Yan B, Zemskova M, Holder S, Chin V, Kraft A, Koskinen PJ et al. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 2003;278:45358-45367.
138. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the SeM 12 gatekeeper site. FESS Lett 2004; 571:43-49.
139. Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003;285: H1506-H1514.
140. Uchiyama T, Engelman RM, Maulik N, Das DK. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 2004; 109:3042-3049.
141. Horbinski C, Chu CT. Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radie Biol Med 2005;38:2 11.
142. Ahmad N, Wang Y, Haider KH, Wang B, Pasha Z, Uzun O et al. Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am J Physiol Heart Circ Physiol 2006;290:H2402-H2408.
143. Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 2006;38:414-419.
144. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 2007;20:1-22.
145. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113:1535-1549.
146. Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the mitochondria: Akting on apoptosis. Cell Signal 2008;20:21-30.
147. Adams JW, Pagel AL, Means CK, Oksenberg D, Armstrong RC, Brown JH. Cardiomyocyte apoptosis induced by Galphaq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res 2000;87:1180-1187.
148. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434:652-658.
149. Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, Colbert MC et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 2002;8:725-730.
150. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW 2nd et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003;108:3036-3041.
151. Dorn GW 2nd, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 1999;9:26-34.
152. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003;93:292-301.
153. Scarabelli TM, Knight R, Stephanou A, Townsend P, Chen-Scarabelli C, Lawrence K et al. Clinical implications of apoptosis in ischemic myocardium. Curr Probl Cardiol 2006;31:181-264.
154. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341:233 249.
155. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004;95:957-970.
156. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626-629.
157. Gustafsson AB, Gottlieb RA. Mechanisms of apoptosis in the heart. J Clin Immunol 2003;23:447-459.
158. Green DR. Apoptotic pathways: ten minutes to dead. Cell 2005; 121: 671-674.
159. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005;434:658-662.
160. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004;427:461-465.
161. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltagedependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007;9:550-555.
162. De Marchi U, Campello S, Szabo I, Tombola F, Martinou JC, Zoratti M. Bax does not directly participate in the Ca(2+)-induced permeability transition of isolated mitochondria. J Biol Chem 2004;279:37415-37422.
163. Yang JC, Kahn A, Cortopassi G. Bcl-2 does not inhibit the permeability transition pore in mouse liver mitochondria. Toxicology 2000; 151: 65-72.
164. Nutt LK, Pataer A, Pahler J, Fang B, Roth J, McConkey DJ et al. Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores. J Biol Chem 2002;277:9219-9225.
165. Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003;300:135-139.
166. Palmer AE, Jin C, Reed JC, Tsien RY. Bcl-2-mediated alterations in endoplasmic reticulum Ca2 + analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci USA 2004;101:17404-17409.
167. Diwan A, Matkovich SJ, Yuan Q, Zhao W, Yatani A, Brown JH et al. Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death. J Clin Invest 2009; 119:203 212.
168. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001; 104:330 335.
169. Kuwahara K, Saito Y, Kishimoto I, Miyamoto Y, Harada M, Ogawa E et al. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol 2000;32:1385-1394.
170. Craig R, Wagner M, McCardle T, Craig AG, Glembotski CC. The cytoprotective effects of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of NF-kappa B. J Biol Chem 2001; 276:37621 37629.
171. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogenactivated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 1997;272:5783-5791.
172. Robert P, Tsui P, Laville MP, Livi GP, Sarau HM, Bril A et al. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol 2001;33:1589-1606.
173. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 2001 ;98: 1607-1612.
174. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta EG et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 2000;87:1172-1179.
175. Naga Prasad SV, Esposito G, Mao L, Koch WJ, Rockman HA. Gbetagammadependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 2000;275:4693-4698.
176. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, lshii I et al. Sphingosine 1phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007; 292: H2944-H2951.
177. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001 ;89: 1191-1198.
178. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO et al. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 2002;282:H1970-H1977.
179. Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 2002;34:661-668.
180. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 2000;87:309-315.
181. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008;88:581-609.
182. Kunkel MT, Ni Q, Tsien RY, Zhang J, Newton AC. Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J Biol Chem 2005;280:5581-5587.
183. Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-ll. Cell Death Differ 2008;15:521-529.
184. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Yet al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241.
185. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. lnterleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-689.
186. Aikawa R, Nawano M, Gu Y, Katagiri H, AsanoT, Zhu Wet al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000;102:2873-2879.
187. Yamaguchi H, Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001;20:7779-7786.
188. Arokium H, Ouerfelli H, Velours G, Camougrand N, Vallette FM, Manon S. Substitutions of potentially phosphorylatable serine residues of Bax reveal how they may regulate its interaction with mitochondria. J Biol Chem 2007;282:35104-35112.
189. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N et al. Phosphorylation of Bax Ser 184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004;279: 21085-21095.
190. Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, Barhum Y et al. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 2003;284: H2351-H2359.
191. Cai J, Ahmad S, Jiang WG, Huang J, Kontos CD, Boulton M et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 2003;52:2959-2968.
192. Steinberg R, Harari OA, Lidington EA, Boyle JJ, Nohadani M, Samarel AM et al. A protein kinase Cepsilon-anti-apoptotic kinase signaling complex protects human vascular endothelial cells against apoptosis through induction of Bcl-2. J Biol Chem 2007;282:32288-32297.
193. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and Phosphorylase kinase. Eur J Biochem 1980; 107:519 527.
194. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-789.
195. Menon B, Johnson JN, Ross RS, Singh M, Singh K. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptorstimulated apoptosis in adult rat ventricular myocytes: Role of betai integrins. JMoI Cell Cardiol 2007;42:653-661.
196. Hirotani S, Zhai P, Tomita H, Galeotti J, Marquez JP, Gao S et al. Inhibition of glycogen synthase kinase 3beta during heart failure is protective. Circ Res 2007;101:1164-1174.
197. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008;117:2761-2768.
198. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res 2008;103:983-991.
199. Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase Il to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 2005;65:10545-10554.
200. Nishino Y, Webb IG, Davidson SM, Ahmed Al, Clark JE, Jacquet S et al. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res 2008; 103: 307-314.
201. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. MoI Cell 2006;21: 749-760.
202. Mills JR, Hippo Y, Robert F, Chen SM, Malina A, Lin CJ et al. mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sd USA 2008;105:10853 10858.
203. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 2003;206:2049- 2057.
204. Wilson JE. Hexokinases. Rev Physiol Biochem Pharmacol 1995; 126: 65-198.
205. Penso J, Beitner R. Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur J Pharmacol 1998;342:113-117.
206. Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2006;25: 4683-4696.
207. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of Pl 3-kinase and Akt. J Mol Cell Cardiol 2005;38:63-71.
208. Pastorino JG, Hoek JB. Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr Med Chem 2003; 10:1535 1551.
209. MathupalaSP, KoYH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006;25:4777 4786.
210. Pedersen PL. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the 'Warburg Effect', i.e. elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 2007;39:211 222.
211. Bryson JM, Coy PE, Gottlob K, Hay N, Robey RB. Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem 2002; 277: 11392-11400.
212. Ahmad A, Ahmad S, Schneider BK, Allen CB, Chang LY, White CW. Elevated expression of hexokinase Il protects human lung epithelial-like A549 cells against oxidative injury. Am J Physiol Lung Cell MoI Physiol 2002;283:L573 1584.
213. Azoulay-Zohar H, lsraelson A, Abu-Hamad S, Shoshan-Barmatz V. In selfdefence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 2004;377:347-355.
214. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004;16:819-830.
215. CHlara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M et al. Hexokinase Il detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltagedependent anion channels. PLoS ONE 2008;3:e1852.
216. Sun L, ShukairS, NaikTJ, Moazed F, Ardehali H. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol 2008;28:1007 1017.
217. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 2002;277:7610-7618.
218. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 2001;15:1406- 1418.
219. Zuurbier CJ, Eerbeek O, Meijer AJ. Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution. Am J Physiol Heart Circ Physiol 2005;289:H496-H499.
220. Southworth R, Davey KA, Warley A, Garlick PB. A reevaluation of the roles of hexokinase I and II in the heart. Am J Physiol Heart Circ Physiol 2007;292:H378-H386.
221. Majewski N, Nogueira V, Robey RB, Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol Cell Biol 2004;24:730 740.
222. Chen M, Zsengeller Z, Xiao CY, Szabo C. Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc Res 2004;63:682 688.
223. Kim NH, Kim K, Park WS, Son HS, Bae Y. PKB/Akt inhibits ceramide-induced apoptosis in neuroblastoma cells by blocking apoptosis-inducing factor (AIF) translocation. J Cell Biochem 2007; 102:1160-1170.
224. Yang L, Sun M, Sun XM, Cheng GZ, Nicosia SV, Cheng JQ. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. J Biol Chem 2007;282:10981-10987.
225. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321.
226. Miyamoto S, Howes AL, Adams JW, Dorn GW 2nd, Brown JH. Ca2+ dysregulation induces mitochondrial depolarization and apoptosis: role of Na + /Ca2+ exchanger and Akt. J Biol Chem 2005;280:38505-38512.
227. Formisano L, Saggese M, Secondo A, Sirabella R, Vito P, Valsecchi V et al. The two isoforms of the Na i /Ca2+ exchanger, NCX1 and NCX3, constitute novel additional targets for the prosurvival action of Akt/protein kinase B pathway. Mol Pharmacol 2008;73:727-737.
228. Avkiran M, Cook AR, Cuello F. Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? Curr Opin Pharmacol 2008;8: 133-140.
229. Snabaitis AK, Cuello F, Avkiran M. Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1. Circ Res 2008;103: 881-890.
230. Khan MT, Wagner L 2nd, Yule Dl, Bhanumathy C, Joseph SK. Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. J Biol Chem 2006;281:3731-3737.
231. Szado T, Vanderheyden V, Parys JB, De Smedt H, Rietdorf K, Kotelevets L et al. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci USA 2008;105:2427-2432.
232. Szalai G, Krishnamurthy R, Hajnoczky G. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J 1999;18:6349-6361.
233. Jaconi M, Bony C, Richards SM, Terzic A, Arnaudeau S, Vassort G et al. Inositol 1,4,5-trisphosphate directs Ca(2+) flow between mitochondria and the Endoplasmic/Sarcoplasmic reticulum: a role in regulating cardiac autonomic Ca(2+) spiking. AIoI SIoI Cell 2000; 11:1845 1858.
234. Wu X, Zhang T, Bossuyt J, Li X, McKinsey TA, Dedman JR et al. Local lnsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 2006;116:675 682.
235. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995;95:888-894.
236. Pintón P, Rizzuto R. Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 2006;13:1409-1418.